ALEXANDER WELCH: Open Payments
NPI 1922383827 · DENVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,370 in 76 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $511 · 2025 $1,370
Food & beverage: $1,370
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $175 |
| Lilly USA, LLC | 10 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $124 |
| PFIZER INC. | 6 | $114 |
| Novo Nordisk Inc | 6 | $107 |
| ABBVIE INC. | 6 | $103 |
| Exact Sciences Corporation | 3 | $77 |
| Amgen Inc. | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $63 |
Products named: JARDIANCE, Kerendia, REXULTI, BREZTRI, FARXIGA, Cologuard Collection Kit, MOUNJARO, OTEZLA.
Industry payments across NJ — which companies pay providers there.
